IO BIOTECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.42 USD | -2.07% |
|
-4.05% | -24.47% |
| Apr. 26 | IO Biotech, Inc. Announces Resignation of Jack Nielsen as Member of the Board of Directors | CI |
| Apr. 15 | IO Biotech Announces Marjan Shamsaei as Senior Vice President | CI |
Chart calendar IO Biotech, Inc.
3d10ef23bc5551d.7qzy_0fFmpAas6izbA_PJA7wmEa_tdMy1FxqwLZJih4.u5-tsXej0qconpD4I02Mczy13T_t_etLm2wNsIcL2luDxYirIYnT4mvC2w~776e2e146dfa1d6a45f0aede53f97d3b
Upcoming events on IO Biotech, Inc.
Past events on IO Biotech, Inc.
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No : 4094 |
| 2024-03-06 12:50 pm | TD Cowen Health Care Conference |
| 2024-03-05 04:40 pm | Q4 2023 Earnings Release |
| 2023-11-29 04:30 pm | Piper Sandler Healthcare Conference |
| 2023-11-14 | Jefferies London Healthcare Conference |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 1468 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 1335 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 1029 |
| 2023-10-23 03:00 am | European Society for Medical Oncology Congress - Poster No:1038P |
| 2023-10-19 | ESMO Congress - Poster Number: 1038P |
| 2023-09-13 02:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-09-12 04:15 pm | Morgan Stanley Global Healthcare Conference |
| 2023-09-11 10:45 pm | IASLC World Conference |
| 2023-08-11 08:30 am | Q2 2023 Earnings Release |
| 2023-06-08 08:30 am | Annual General Meeting |
| 2023-06-07 12:30 pm | Jefferies Global Healthcare Conference |
| 2023-05-11 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-14 04:11 pm | Q4 2022 Earnings Release |
| 2023-03-14 08:00 am | Oppenheimer Healthcare Conference |
| 2023-03-06 09:10 am | Cowen Health Care Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -41,2 -67,0 38.45% | 0,00 0,00 - | -91,4 -81,1 -12.61% | -95 892 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -41,2 -49,0 15.79% | -71,4 -68,6 -4.17% | -91,4 -88,1 -3.78% | -111 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -67,8 -57,9 -17.17% | -70,7 -68,5 -3.19% | -85,2 -82,8 -2.99% | -105 |
|
Net income Million USD | Released Forecast Spread | -14,6 | -75,0 -58,4 -28.29% | -71,3 -68,7 -3.89% | -86,1 -83,1 -3.55% | -105 |
|
EPS USD | Released Forecast Spread | -82,4 | -17,3 -11,4 -51.49% | -2,48 -2,37 -4.79% | -1,98 -2,03 2.58% | -1,38 |
| Announcement Date | 09/08/21 | 31/03/22 | 14/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -21,4 -11,1 -92.8% | -17,0 -14,0 -21.5% | -18,2 -12,0 -51.34% | -15,9 -16,5 3.57% | -20,4 -17,2 -18.83% | -17,9 -20,9 14.03% | -21,9 -20,6 -6.21% | -23,5 -23,4 -0.36% | -28,2 -24,9 -13.39% | -24,5 | -25,8 | -27,4 | -32,2 | -31,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,2 -11,3 -87.91% | -17,1 -14,0 -22.41% | -18,4 -12,0 -53.26% | -15,6 -16,5 5.39% | -19,6 -17,1 -14.9% | -16,6 -19,6 15.11% | -20,6 -20,0 -3.23% | -22,1 -21,3 -3.72% | -25,8 -23,4 -10.58% | -23,1 | -24,4 | -26,1 | -31,2 | -28,9 |
|
Net income Million USD | Released Forecast Spread | -21,2 -11,3 -87.91% | -17,2 -14,0 -22.89% | -18,5 -12,0 -54.13% | -15,7 -16,5 4.69% | -19,9 -17,1 -16.82% | -17,0 -19,6 13.04% | -21,2 -20,0 -5.89% | -21,7 -21,3 -1.66% | -26,2 -23,4 -12.09% | -23,1 | -24,4 | -26,1 | -31,1 | -28,9 |
|
EPS USD | Released Forecast Spread | -1,33 -0,44 -202.27% | -0,60 -0,50 -20% | -0,64 -0,40 -60% | -0,54 -0,56 3.57% | -0,69 -0,61 -13.74% | -0,59 -0,68 13.24% | -0,74 -0,67 -10.45% | -0,43 -0,33 -31.63% | -0,40 -0,39 -3.9% | -0,35 | -0,37 | -0,31 | -0,37 | -0,26 |
| Announcement Date | 31/03/22 | 16/05/22 | 11/08/22 | 09/11/22 | 14/03/23 | 11/05/23 | 11/08/23 | 13/11/23 | 05/03/24 | - | - | - | - | - |
More events
Past sector events for IO Biotech, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IOBT Stock
- Calendar IO Biotech, Inc.
